Released August 09, 2019 | beijing
en
China has a large number of high-investment active pharmaceutical ingredients (API) projects under construction this year, including Wugan Pharmaceutical Company Limited's new production facility in Changsha. The graph below shows China's investment in the Pharma-Bio sector, by project type.
